Board changes at Benitec, Ventracor, BioDiem
Thursday, 17 February, 2005
The management changes at RNAi player Benitec (ASX:BLT) continued yesterday, with the announcement that company secretary Gary Taylor had resigned as a director of the company. Taylor will remain company secretary.
Ventracor (ASX:VCR) has appointed medical devices executive Peter Crosby as chief operating officer. Crosby -- an Australian who has served as CEO of four international medical device companies -- will take on the marketing, sales and distribution of Ventracor's VentAssist device.
BioDiem (ASX:BDM) has appointed former Deutsche Bank executive Andrew O'Brien to its board as a non-executive director. O'Brien headed the Australian healthcare corporate finance at Deutsche Bank, and currently works for consulting firm BioIncyte.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
